Apellis Pharmaceuticals, Inc., is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in Complement, at the forefront of targeted C3 therapies, we aim to develop transformative therapies for a broad range of debilitating diseases that are driven by uncontrolled or excessive activation of the complement cascade, including those within hematology, ophthalmology, nephrology, and neurology.
Contact this Exhibitor
Text
Cancel OK
